Form 8-K - Current report:
SEC Accession No. 0001493152-24-002364
Filing Date
2024-01-16
Accepted
2024-01-16 09:10:51
Documents
24
Period of Report
2024-01-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 253999
2 form8-k_001.jpg GRAPHIC 97839
3 form8-k_002.jpg GRAPHIC 23597
4 form8-k_003.jpg GRAPHIC 54896
5 form8-k_004.jpg GRAPHIC 23111
6 form8-k_005.jpg GRAPHIC 23938
7 form8-k_006.jpg GRAPHIC 32488
8 form8-k_007.jpg GRAPHIC 22920
9 form8-k_008.jpg GRAPHIC 26727
10 form8-k_009.jpg GRAPHIC 24756
11 form8-k_010.jpg GRAPHIC 29391
12 form8-k_011.jpg GRAPHIC 23906
  Complete submission text file 0001493152-24-002364.txt   1413456

Data Files

Seq Description Document Type Size
13 XBRL SCHEMA FILE ogen-20240116.xsd EX-101.SCH 3018
14 XBRL LABEL FILE ogen-20240116_lab.xml EX-101.LAB 34240
15 XBRL PRESENTATION FILE ogen-20240116_pre.xml EX-101.PRE 22361
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3293
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32188 | Film No.: 24533857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)